Haolong Lin
- Topics
- CAR-T cell therapy research (9 papers)Nanowire Synthesis and Applications (3 papers)Virus-based gene therapy research (2 papers)
- Cited by
- OncologyImmunologyGenetics
- Journals
- Science Translational MedicineFrontiers in ImmunologySignal Transduction and Targeted Therapy
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Haolong Lin
10 papers receiving 267 citations
Peers
Comparison fields: 5 of 35
- Oncology 224
- Molecular Biology 95
- Immunology 95
- Genetics 65
- Biomedical Engineering 61
Countries citing papers authored by Haolong Lin
This map shows the geographic impact of Haolong Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haolong Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haolong Lin more than expected).
Fields of papers citing papers by Haolong Lin
This network shows the impact of papers produced by Haolong Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haolong Lin. The network helps show where Haolong Lin may publish in the future.
Co-authorship network of co-authors of Haolong Lin
This figure shows the co-authorship network connecting the top 25 collaborators of Haolong Lin. A scholar is included among the top collaborators of Haolong Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haolong Lin. Haolong Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 41 | |
| 6 | 2 | |
| 7 | 3 | |
| 8 | 1 | |
| 9 | 65 | |
| 10 | 133 | |
| 11 | 7 | |
| 12 | 12 |
About Haolong Lin
Haolong Lin is a scholar working on Oncology, Hematology and Immunology, having authored 12 papers that have together received 270 indexed citations. Recurring topics across this work include CAR-T cell therapy research (9 papers), Nanowire Synthesis and Applications (3 papers) and Virus-based gene therapy research (2 papers). The work is most often cited by research in Oncology (224 citations), Immunology (95 citations) and Genetics (65 citations). Haolong Lin has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Wei Mu, Jianfeng Zhou, Jiali Cheng, Li Zhu, Liang Huang, Xiuxiu Yang, Zhenyu Dai, Chaohong Liu, Meng Wang and Jianwei Liu. Their work appears in journals such as Science Translational Medicine, Frontiers in Immunology and Signal Transduction and Targeted Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.